Use of Palliative Care Services in a Tertiary Cancer Center.

Shalini Dalal, Sebastian Bruera, David Hui, Sriram Yennu, Rony Dev, Janet Williams, Charles Masoni, Ijeoma Ihenacho, Emmanuel Obasi, Eduardo Bruera
Author Information
  1. Shalini Dalal: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA sdalal@mdanderson.org.
  2. Sebastian Bruera: Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
  3. David Hui: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  4. Sriram Yennu: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  5. Rony Dev: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  6. Janet Williams: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  7. Charles Masoni: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  8. Ijeoma Ihenacho: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  9. Emmanuel Obasi: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  10. Eduardo Bruera: Department of Palliative Care and Rehabilitation Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Abstract

BACKGROUND: Despite increasing prevalence of palliative care (PC) services in cancer centers, most referrals to the service occur exceedingly late in the illness trajectory. Over the years, we have made several attempts to promote earlier patient access to our PC program, such as changing the name of our service from PC to supportive care (SC). This study was conducted to determine the use of PC/SC service over the past 8 years.
METHODS: We reviewed billing data for all PC/SC encounters. We examined five metrics for use: inpatient consultations as a percentage of hospital admissions, ratio of inpatient consultations to average number of operational beds, time from hospital registration to outpatient consultation, time from advanced cancer diagnosis to consultation, and time from first outpatient consultation to death/last follow-up.
RESULTS: Over the years, we found a consistent increase in patient referrals to the PC/SC program. In the inpatient setting, we found approximate doubling of the inpatient consultations as a percentage of hospital admissions and the ratio of inpatient consultations to hospital beds (from 10% to 19% and from 2.4 to 4.9, respectively; p < .001). In the outpatient setting, we observed variations in referral pattern between oncology services, but, overall, the time from consultation to death/last follow-up increased from 4.8 months to 7.9 months (p = .001), which was accompanied by a significant decrease in the interval to consultation from hospital registration and advanced cancer diagnosis (p < .001).
CONCLUSION: We have observed a consistent annual increase in new patient referrals as well as earlier access for outpatient referrals to our SC service, supporting increased use of palliative care at our cancer center.
IMPLICATIONS FOR PRACTICE: In response to accumulating evidence on the benefits of palliative care (PC) referral to oncology patients, efforts are being made to increase PC use. This study, conducted at MD Anderson Cancer Center, demonstrates consistent annual growth in PC referrals, which was accompanied by a significant increase in the outpatient referral of patients with nonadvanced cancer and earlier referral of those with advanced cancer. However, significant variations in the referral patterns between oncology services were observed. These results have implications for other cancer centers looking to enhance use of PC services by having a business model that allows for appropriate space and staff expansion.

Keywords

References

  1. J Palliat Med. 2006 Oct;9(5):1128-36 [PMID: 17040151]
  2. Oncol Nurs Forum. 2002 Nov-Dec;29(10):1421-8 [PMID: 12432413]
  3. J Palliat Med. 2008 Jan-Feb;11(1):51-7 [PMID: 18370893]
  4. J Clin Oncol. 2008 Aug 10;26(23):3832-7 [PMID: 18688049]
  5. J Palliat Med. 2008 Dec;11(10):1294-8 [PMID: 19115885]
  6. Cancer. 2009 May 1;115(9):2013-21 [PMID: 19235253]
  7. Support Care Cancer. 2009 Sep;17(9):1223-30 [PMID: 19184126]
  8. JAMA. 2009 Aug 19;302(7):741-9 [PMID: 19690306]
  9. Ann Oncol. 2010 Feb;21(2):362-9 [PMID: 19654197]
  10. JAMA. 2010 Mar 17;303(11):1054-61 [PMID: 20233823]
  11. N Engl J Med. 2010 Aug 19;363(8):733-42 [PMID: 20818875]
  12. J Palliat Med. 2010 Oct;13(10):1261-6 [PMID: 20879874]
  13. Oncologist. 2011;16(1):105-11 [PMID: 21212438]
  14. Lancet Oncol. 2011 Feb;12(2):160-74 [PMID: 21251875]
  15. J Clin Oncol. 2012 Mar 10;30(8):880-7 [PMID: 22312101]
  16. Ann Oncol. 2012 Apr;23 Suppl 3:70-5 [PMID: 22628420]
  17. J Natl Compr Canc Netw. 2012 Oct 1;10(10):1284-309 [PMID: 23054879]
  18. Oncologist. 2012;17(12):1574-80 [PMID: 23220843]
  19. J Pain Symptom Manage. 2013 Feb;45(2):261-71 [PMID: 22889857]
  20. J Natl Compr Canc Netw. 2013 Mar;11 Suppl 1:S11-6 [PMID: 23520181]
  21. Palliat Support Care. 2013 Oct;11(5):397-404 [PMID: 23302500]
  22. J Pain Symptom Manage. 2013 Nov;46(5):652-60 [PMID: 23566756]
  23. Lancet. 2014 May 17;383(9930):1721-30 [PMID: 24559581]
  24. Support Care Cancer. 2000 May;8(3):175-9 [PMID: 10789956]
  25. Ann Oncol. 2015 Sep;26(9):1953-9 [PMID: 26088196]
  26. J Pain Symptom Manage. 2004 Apr;27(4):310-5 [PMID: 15050658]
  27. J Clin Oncol. 2005 Apr 20;23(12):2637-44 [PMID: 15728219]
  28. J Palliat Med. 2005 Oct;8(5):1025-32 [PMID: 16238515]
  29. Cancer. 2014 Jun 1;120(11):1743-9 [PMID: 24967463]
  30. J Pain Symptom Manage. 2011 Jan;41(1):49-56 [PMID: 20739141]
  31. Oncologist. 2015 Jan;20(1):77-83 [PMID: 25480826]
  32. J Clin Oncol. 2015 May 1;33(13):1438-45 [PMID: 25800768]
  33. Support Care Cancer. 2008 Mar;16(3):217-22 [PMID: 17318594]

Grants

  1. R01NR010162-01A1/NINR NIH HHS
  2. R01 CA124481/NCI NIH HHS
  3. R01CA122292-01/NCI NIH HHS
  4. R21 CA186000/NCI NIH HHS
  5. R21CA186000-01A1/NCI NIH HHS
  6. R01 CA122292/NCI NIH HHS
  7. R01 NR010162/NINR NIH HHS
  8. R01CA124481-01/NCI NIH HHS

MeSH Term

Hospitalization
Humans
Neoplasms
Palliative Care
Terminal Care
Tertiary Care Centers

Word Cloud

Created with Highcharts 10.0.0PCcancercarereferralsinpatienthospitaloutpatientconsultationreferralservicesserviceuseconsultationstimeincreasepalliativeyearsearlierpatientPC/SCadvancedconsistent4p001observedoncologysignificantCancercentersmadeaccessprogramSCstudyconducted8percentageadmissionsratiobedsregistrationdiagnosisdeath/lastfollow-upfoundsetting9<variationsincreasedmonthsaccompaniedannualpatientsCenterPalliativeCareBACKGROUND:DespiteincreasingprevalenceoccurexceedinglylateillnesstrajectoryseveralattemptspromotechangingnamesupportivedeterminepastMETHODS:reviewedbillingdataencountersexaminedfivemetricsuse:averagenumberoperationalfirstRESULTS:approximatedoubling10%19%2respectivelypatternoverall7=decreaseintervalCONCLUSION:newwellsupportingcenterIMPLICATIONSFORPRACTICE:responseaccumulatingevidencebenefitseffortsMDAndersondemonstratesgrowthnonadvancedHoweverpatternsresultsimplicationslookingenhancebusinessmodelallowsappropriatespacestaffexpansionUseServicesTertiaryEnd-of-lifeSupportive

Similar Articles

Cited By (28)